RESUMEN
BACKGROUND AND AIMS: Despite the use of antifungal drugs, the visceral candidiasis is associated with a high mortality rate. The aims of this study were an evaluation of intrinsic and acquired immune cells infiltration in kidney and spleen of the mice infected with systemic candidiasis and treated with chloroform fraction of Zataria Multiflora Boiss. MATERIALS AND METHODS: Candida albicans (C. albicans) ATCC10231 clinical standard strain was isolated. C. albicans LD50 was determined. The laboratory animal (BALB/C mouse) infection with the visceral candidiasis was performed. The kidney and spleen tissues were stained with PAS and prepared for confirmation under the microscope. The Zataria Multiflora Boiss (Shiraz thyme) was prepared and the effects on the infected group were assessed. The kidney and spleen mononuclear cells (MNCs) were prepared and the flow cytometry technique was performed for the assessment of Th1, Th17, and Treg cells. RESULTS: The LD50 and LD totals were 1.5 × 108 and 2 × 108 Yeast/0.1 ml, respectively. In mice which had a drug intervention, including chloroform fraction of Zataria Multiflora Boiss, thymol, carvacrol or fluconazole, fungal purification was greater in the spleen than in the kidney. Among those mice without medication intervention, fungal clearance was higher in the kidney. The highest percentage of TH1 cells was in group 1 and then group 4 and in groups 2 and 3 respectively. Moreover, there was a significant difference between groups 4 and 5 and also 6 and 7. The percentage of TH1 cells in the spleen MNCs was higher than that of the kidney cells, which is the difference between the groups except for group 7. The percentage of TH17 cells in the kidney and spleen of all drug-receiving groups exhibited a significant increase compared to groups 6 and 7. The percentage of Treg cells in the kidney and the spleen only in the extract-receiving group had a significant decrease compared to the non-drug receiving group and the other groups receiving group depicted no significant difference in the percentage of Treg cells. CONCLUSION: In addition to the direct effect on the fungus proven in vitro, the extract exhibits immunosuppressive effects, and thus can degrade the fungus through this way. The results demonstrated that the fraction of Zataria Multiflora Boiss can be considered as a powerful alternative to C. albicans therapy along with other therapies.
Asunto(s)
Antifúngicos/farmacología , Candidiasis/tratamiento farmacológico , Candidiasis/inmunología , Riñón/inmunología , Lamiaceae/química , Extractos Vegetales/farmacología , Bazo/inmunología , Animales , Candida albicans/efectos de los fármacos , Candida albicans/patogenicidad , Estudios de Casos y Controles , Recuento de Células , Cloroformo , Modelos Animales de Enfermedad , Femenino , Riñón/efectos de los fármacos , Riñón/microbiología , Dosificación Letal Mediana , Leucocitos Mononucleares/efectos de los fármacos , Leucocitos Mononucleares/inmunología , Ratones , Ratones Endogámicos BALB C , Bazo/efectos de los fármacos , Bazo/microbiología , Linfocitos T Reguladores/efectos de los fármacos , Linfocitos T Reguladores/inmunología , Células TH1/efectos de los fármacos , Células TH1/inmunología , Células Th17/efectos de los fármacos , Células Th17/inmunologíaRESUMEN
OBJECTIVE: Aflatoxin B1 (AFB1) suppresses the immune system. To decrease such suppressive effects on the immune system, a wide range of herbal medicines like garlic are utilized. Biological activities of garlic in vitro and in vivo have also been verified. Our previous studies demonstrated that aged garlic (dry garlic bulbs preserved in the freezer for six months at -20ËC) have increased immunostimulator fractions and reduced immunosuppressor fractions. This study focuses on the immunosuppressor activity of AFB1 and immunostimulator activity of aged garlic extract (AGE) through the evaluation of CD4(+) CD25(+) FoxP(+) regulator cell (Treg) counts and the pattern of cytokine production in Balb/c normal mice. MATERIALS AND METHODS: In this experimental research, AFB1 was separated from Aspergillus flavus (PTCC 5004) by HPLC and AGE prepared using the Mantis method. The Delayed-Type Hypersensitivity (DTH) test was carried out to determinate the effectiveness of different doses of AGE and AFB1, which can both have an effect on the immune system. Subsequent experiments were carried out on 20 Balb/c mice to estimate the effects of AGE and AFB1 on the number of Treg cell in 4 groups: 10 µl/kg/day of AFB1 and AGE diluents were administered for 4 consecutive days to group 1. AFB1, 2. control, 3. AGE + AFB1 and 4. AGE via intraperitoneal (IP) route, respectively. Mice were sacrificed and splenocytes harvested and the percentage of splenic Treg cells was measured by flow cytometry analysis. The ELISA method was utilized to measure Cytokine production. RESULTS: The findings reveal that AGE increased the level of IFN-λ and IL-4 cytokines produced by splenocytes stimulated by specific tumor antigen and decreased the number of Treg cells in the spleen (p<0.05). AFB1 increased the number Treg cells in the spleen and decreased cytokine production (p<0.05). In groups 2 (control) and 4 (AGE) the number of Treg cells decreased (p value<0.05) whereas in groups 1 and 3 the number of Treg cells increased (p<0.05). CONCLUSION: This study indicated that AGE is able to alter the cytokine production in normal mice into a Th1 protective pattern which is beneficial to the immune system in general and anti-tumor immunity in particular. AFB1 is able to alter the cytokine production into a Th2 protective pattern. Therefore, AGE might be used as herbal medicine with few side effects as compared to chemotherapy in treating cancers caused by substances like AFB1.